Who are the Institutional Holders in Milestone Scientific Inc. (MLSS)?

66 institutions hold shares in Milestone Scientific Inc. (MLSS), with 20.74M shares held by insiders accounting for 32.56% while institutional investors hold 17.34% of the company’s shares. The shares outstanding are 65.82M, and float is at 43.20M with Short Float at 5.28%. Institutions hold 11.70% of the Float.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 2.55 million shares valued at $5.4 million. The investor’s holdings represent 4.00% of the MLSS Shares outstanding. As of Dec 30, 2020, the second largest holder is Blackrock Inc. with 2.11 million shares valued at $4.48 million to account for 3.31% of the shares outstanding. The other top investors are Bridgeway Capital Management, Inc. which holds 0.58 million shares representing 0.90% and valued at over $1.22 million, while State Street Corporation holds 0.85% of the shares totaling 0.54 million with a market value of $1.15 million.

Milestone Scientific Inc. (AMEX: MLSS) is 76.89% higher on its value in year-to-date trading and has touched a low of $0.85 and a high of $4.39 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MLSS stock was last observed hovering at around $4.11 in the last trading session, with the day’s loss setting it -0.36% off its average median price target of $7.00 for the next 12 months. It is also 46.43% off the consensus price target high of $7.00 offered by 2 analysts, but current levels are 46.43% higher than the price target low of $7.00 for the same period.

Currently trading at $3.75, the stock is 12.01% and 39.89% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.01 million and changing -8.76% at the moment leaves the stock 85.13% off its SMA200. MLSS registered 51.21% gain for a year compared to 6-month gain of 114.29%. The firm has a 50-day simple moving average (SMA 50) of $3.0173 and a 200-day simple moving average (SMA200) of $2.0161.

The stock witnessed a 36.86% loss in the last 1 month and extending the period to 3 months gives it a 148.34%, and is 2.74% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.39% over the week and 9.62% over the month.

Milestone Scientific Inc. (MLSS) has around 16 employees, a market worth around $235.39M and $5.50M in sales. Distance from 52-week low is 341.18% and -14.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-236.30%).

Milestone Scientific Inc. (MLSS) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Milestone Scientific Inc. (MLSS) is a “Overweight”. 2 analysts offering their recommendations for the stock have an average rating of 2.50, where 1 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Milestone Scientific Inc. is expected to release its quarterly report on 05/18/2021 and quarterly earnings per share for the current quarter are estimated at -$0.02 with sales reaching $2.01M over the same period.The EPS is expected to grow by 21.90% this year, but quarterly earnings will post -37.60% year-over-year. Quarterly sales are estimated to shrink -12.60% in year-over-year returns.

Milestone Scientific Inc. (MLSS) Insider Activity

A total of 78 insider transactions have happened at Milestone Scientific Inc. (MLSS) in the last six months, with sales accounting for 47 and purchases happening 31 times. The most recent transaction is an insider sale by Bernhard Leslie, the company’s Director. SEC filings show that Bernhard Leslie sold 20,000 shares of the company’s common stock on Feb 17 at a price of $3.61 per share for a total of $72200.0. Following the sale, the insider now owns 45000.0 shares.

Milestone Scientific Inc. disclosed in a document filed with the SEC on Feb 16 that Bernhard Leslie (Director) sold a total of 25,000 shares of the company’s common stock. The trade occurred on Feb 16 and was made at $3.87 per share for $96750.0. Following the transaction, the insider now directly holds 65000.0 shares of the MLSS stock.

Still, SEC filings show that on Feb 11, Trombetta Giandomenico (Director) disposed off 10,000 shares at an average price of $3.85 for $38500.0. The insider now directly holds 9,921,039 shares of Milestone Scientific Inc. (MLSS).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Milestone Scientific Inc. (MLSS): Who are the competitors?

The company’s main competitors (and peers) include Align Technology Inc. (ALGN) that is trading 122.68% up over the past 12 months. DENTSPLY SIRONA Inc. (XRAY) is -6.88% down on the 1-year trading charts. Short interest in the company’s stock has risen 12.28% from the last report on Dec 30, 2020 to stand at a total of 2.0 million short shares sold with a short interest ratio of 3.73.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free